Health & Veritas Scott Berkowitz: Value-Based Care and Population Health
Apr 18, 2024
Scott Berkowitz, a cardiologist and chief population health officer at Johns Hopkins Medicine, discusses the urgent shift from fee-for-service to value-based care. He highlights how current incentives distort priorities in healthcare delivery and advocates for sharing quality data across specialties to enhance patient value. Berkowitz also emphasizes the need for integrating various healthcare services under a unified population health strategy while sharing personal insights on mentorship and balancing leadership with family commitments.
AI Snips
Chapters
Transcript
Episode notes
Distrust Drives Health Misinformation
- Anti-government sentiment helps explain why anti-vaccine and pro-ivermectin views coalesce in the U.S..
- Harlan Krumholz argues distrust of agencies like the FDA fuels misinformation and resistance to public health guidance.
Randomized Trials Thwarted Ivermectin Hype
- Multiple large randomized trials and a systematic review found ivermectin did not improve key COVID-19 outcomes.
- Scott Berkowitz and Harlan Krumholz emphasize the robust negative evidence despite initial in vitro signals.
Expose Clinicians To Value Data
- Share quality and utilization data across departments so every clinician sees how they affect total cost of care.
- Scott Berkowitz advises linking metrics to divisions, including inpatient, outpatient, and post-acute care, to realign incentives.